SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-044144
Filing Date
2017-07-06
Accepted
2017-07-06 17:16:28
Documents
2
Period of Report
2017-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2232
2 POA DOCUMENT poa.txt EX-24.3_735667 3169
  Complete submission text file 0001209191-17-044144.txt   6741
Mailing Address
Business Address
MERRIWEATHER ALFRED G (Reporting) CIK: 0001211839 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36399 | Film No.: 17953176

Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences